Latest updates for Optscureal Limited
Fresh curated links around Optscureal Limited are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
- OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do
OSR Holdings is now OSR Health, reflecting its mission to advance healthcare innovation across biotechnology, medical technology and wellness markets.
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1
Ocular Therapeutix delivers FDA-approved eye therapies and devices, supported by a pipeline targeting multiple ocular diseases.
CEO Statement to Shareholders
OSR Holdings CEO update on Nasdaq compliance, strategic biotech portfolio progress, and long-term value creation across subsidiaries in 2026
OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction
Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level
Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
OSR Health, A Message From the CEO
Read the CEO’s letter outlining OSR Health’s proposed Shareholder Loyalty CVR Program, VXM01 progress, Woori IO and the company’s long-term strategy
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.